The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Rac-2-(5-Ethylthiophen-2-yl)-6-fluoro-3-(4-fluorobenzyl)-2,3-dihydroquinazolin-4(1H)-one ID: ALA3322091
Cas Number: 1542098-94-1
PubChem CID: 72720908
Max Phase: Preclinical
Molecular Formula: C21H18F2N2OS
Molecular Weight: 384.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc(C2Nc3ccc(F)cc3C(=O)N2Cc2ccc(F)cc2)s1
Standard InChI: InChI=1S/C21H18F2N2OS/c1-2-16-8-10-19(27-16)20-24-18-9-7-15(23)11-17(18)21(26)25(20)12-13-3-5-14(22)6-4-13/h3-11,20,24H,2,12H2,1H3
Standard InChI Key: SVXVTSKHYHQIPJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
1.9277 -10.8873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9265 -11.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6414 -12.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6395 -10.4745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3549 -10.8836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3583 -11.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0735 -12.1211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7900 -11.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7865 -10.8778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0667 -10.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5056 -12.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0622 -9.6392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5945 -12.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4015 -13.1052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8105 -12.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2560 -11.7795 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.6305 -12.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1185 -12.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4997 -10.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4971 -9.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2127 -9.2269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2105 -8.4026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4942 -7.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7788 -8.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7844 -9.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4906 -7.1665 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2132 -10.4750 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 1 0
10 12 2 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 11 1 0
15 17 1 0
17 18 1 0
9 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
1 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.45Molecular Weight (Monoisotopic): 384.1108AlogP: 5.36#Rotatable Bonds: 4Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.11CX Basic pKa: ┄CX LogP: 6.29CX LogD: 6.29Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -1.49
References 1. Carney DW, Nelson CD, Ferris BD, Stevens JP, Lipovsky A, Kazakov T, DiMaio D, Atwood WJ, Sello JK.. (2014) Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses., 22 (17): [PMID:25087050 ] [10.1016/j.bmc.2014.06.053 ]